Evidence map›Paper›PMID 37975866›Full record

ArticleBioinformatics (Oxford, England)2023

gmcoda: Graphical model for multiple compositional vectors in microbiome studies.

Huaying Fang

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Huaying FangBeijing Advanced Innovation Center for Imaging Theory and Technology, Capital Normal University, Beijing 100048, China.ORCID 0000-0002-7693-8260

Funding

National Natural Science Foundation of China 12101425
6 · The paper itself

Abstract

motivationMicrobes are essential components in the ecosystem and participate in most biological procedures in environments. The high-throughput sequencing technologies help researchers directly quantify the abundance of microbes in a natural environment. Microbiome studies explore the construction, stability, and function of microbial communities with the aid of sequencing technology. However, sequencing technologies only provide relative abundances of microbes, and this kind of data is called compositional data in statistics. The constraint of the constant-sum requires flexible statistical methods for analyzing microbiome data. Current statistical analysis of compositional data mainly focuses on one compositional vector such as bacterial communities. The fungi are also an important component in microbial communities and are always measured by sequencing internal transcribed spacer instead of 16S rRNA genes for bacteria. The different sequencing methods between fungi and bacteria bring two compositional vectors in microbiome studies.

resultsWe propose a novel statistical method, called gmcoda, based on an additive logistic normal distribution for estimating the partial correlation matrix for cross-domain interactions. A majorization-minimization algorithm is proposed to solve the optimization problem involved in gmcoda. Through simulation studies, gmcoda is demonstrated to work well in estimating partial correlations between two compositional vectors. Gmcoda is also applied to infer cross-domain interactions in a real microbiome dataset and finds potential interactions between bacteria and fungi. AVAILABILITY AND IMPLEMENTATION: Gmcoda is open source and freely available from https://github.com/huayingfang/gmcoda under GNU LGPL v3.

Indexed as

MicrobiotaAlgorithmsBacteriaComputer SimulationHigh-Throughput Nucleotide SequencingRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID37975866
PMCPMC10681862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.